Empowering RNA Therapeutics Research with Benchling's Complete R&D Platform

KB at your finger tips

This is one stop global knowledge base where you can learn about all the products, solutions and support features.

Products-Benchling

Empowering RNA Therapeutics Research with Benchling's Complete R&D Platform

Revolutionizing RNA Therapeutics Research

The field of RNA therapeutics holds immense promise in targeting diseases that were previously considered 'undruggable.' With the ability to achieve results that were inaccessible to small molecules and antibodies, companies focusing on RNA therapeutics are paving the way for groundbreaking treatments. These advancements are made possible through intensive research in RNA biology and chemical modifications of oligonucleotides, mRNA, and RNA sequences to enhance their biophysical properties.

Challenges in RNA Therapeutics R&D

Traditional software designed for small molecules or antibodies lacks the necessary capabilities to support the complex requirements of RNA therapeutics research. To address this gap, a new approach is needed to integrate biological and chemical properties seamlessly. R&D teams in this field require digital solutions that can establish a unified data foundation and ensure traceability across sequences, chemical modifications, experiments, and process development.

Benchling's RNA Therapeutics Solution

Developed in collaboration with industry leaders, Benchling's RNA Therapeutics Solution offers a comprehensive platform for designing and developing natural and chemically modified oligonucleotides, mRNA, and other RNA sequences. This advanced solution enables R&D teams to centralize experimental results, standardize sequence design, and collaborate effectively, all within a single platform. By combining in silico design tools, Electronic Lab Notebook (ELN), and Laboratory Information Management System (LIMS) features, Benchling provides a modern, unified, and highly configurable solution that evolves with the dynamic needs of RNA therapeutics R&D.

Benefits of Benchling's Solution

Benchling's RNA Therapeutics Solution simplifies collaboration across multidisciplinary teams by providing intuitive design tools, centralizing experimental data, and standardizing sequence design. Moreover, it enhances data quality and offers real-time scientific insights by ensuring consistent records across experiments and aggregating results for visualization. With customizable decision support tools, Benchling accelerates the entire RNA therapeutic lifecycle by facilitating rapid iteration on oligo candidates.

Support and Expertise

Benchling's Customer Experience professionals offer dedicated expertise to support RNA therapeutic customers, combining scientific knowledge with IT best practices. Through continuous oversight and pre-implementation solutions consulting, Benchling ensures that customers derive maximum value from the platform. Additionally, R&D teams can access foundational implementation guides developed by Benchling's Customer Experience team to streamline their workflows.

Stay Ahead in Today’s Competitive Market!
Unlock your company’s full potential with a Virtual Delivery Center (VDC). Gain specialized expertise, drive seamless operations, and scale effortlessly for long-term success.

Book A Meeting To Setup A VDC

Accelerate Microbial Strain R&D with Benchling Solutions

Introduction to Microbial Strain R&D Solution

In the realm of sustainable bio-based innovations, microbial strains play a crucial role in revolutionizing industries such as industrial biotech, food and beverage, sustainable materials, and consumer goods. The advancements in synthetic biology and metabolic engineering have paved the way for creating novel strains that enhance the sustainable production of proteins, small molecules, and cellular products. To expedite the development of optimal microbes, strain research teams are adopting sophisticated techniques like strain engineering, high-throughput fermentation screening, parallel bioprocessing, and analytical automation.

Read article

Revolutionizing In Vivo Studies with Benchling In Vivo

Optimizing In Vivo Studies with Benchling

Benchling's In Vivo solution offers a cutting-edge platform designed to revolutionize in vivo studies, enabling companies to manage these studies efficiently with modern software geared towards data capture, collaboration, and insights. This innovative tool ensures that teams can save time and generate accurate in vivo study data as part of their connected R&D process. With Benchling In Vivo, researchers can accelerate study startup, capture in-life study data, and drive collaboration effectively.

Read article

Revolutionizing Large Molecule Bioprocess Development with Benchling: A Case Study with Gilead Sciences

Introduction to Gilead Sciences and Benchling Partnership

Gilead Sciences, a renowned biopharmaceutical company dedicated to medical breakthroughs, partnered with Benchling to enhance large molecule bioprocess development. With a focus on novel therapies for life-threatening diseases, Gilead sought to bolster scientist productivity, collaboration, and data insights to elevate efficiency and predictability in their development processes.

Read article

Optimizing Agritech Research and Development with Benchling

The Importance of Agritech R&D in Revolutionizing Agriculture

Agricultural technology, or agritech, has become a key player in shaping modern farming practices. With the goal of increasing food security, reducing greenhouse gas emissions, and utilizing natural resources efficiently, agritech R&D plays a crucial role in driving innovation within the agricultural industry. To achieve these breakthroughs, research and development teams require sophisticated informatics tools that can integrate data across various domains, including chemistry, genomics, and sample tracking.

Read article

Revolutionizing Antibody and Protein R&D with Benchling Solutions

The Evolution of Antibody R&D

The field of antibodies and proteins is witnessing a transformative era in the fight against critical illnesses like cancer and immune system disorders. Innovations in monoclonal antibody technology, bispecifics, and antibody-drug conjugates are paving the way for more effective treatments with enhanced safety profiles. Antibody research and development (R&D) teams are embracing diverse formats, integrating cutting-edge technologies such as Next-Generation Sequencing (NGS) and CRISPR, and automating key processes to drive the development of groundbreaking antibodies.

Read article

Welcome to Knowledge Base!

KB at your finger tips

Products-Benchling